{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T18:44:42Z","timestamp":1777056282715,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","brachyjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.brachy.2023.11.001","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T12:29:43Z","timestamp":1703852983000},"page":"173-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety of high-dose rate (HDR) brachytherapy for patients with prostate cancer and history of prior chemoradiation for rectal cancer: A case series"],"prefix":"10.1016","volume":"23","author":[{"given":"Horatio","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5380-4825","authenticated-orcid":false,"given":"Jie Jane","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8504-4847","authenticated-orcid":false,"given":"Hasan","family":"Abdul-Baki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6826-959X","authenticated-orcid":false,"given":"Ali","family":"Sabbagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitham","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1127-4504","authenticated-orcid":false,"given":"Oi Wai","family":"Chau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1435-5959","authenticated-orcid":false,"given":"Nauman","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9396-4960","authenticated-orcid":false,"given":"Alan","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Comron","family":"Hassanzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Chow","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2972-657X","authenticated-orcid":false,"given":"Osama","family":"Mohamad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.brachy.2023.11.001_bib0001","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.brachy.2023.11.001_bib0002","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1754-9485.2012.02358.x","article-title":"HDR brachytherapy combined with external beam radiation for localised prostate cancer: early experience from the Sydney Cancer Centre","volume":"56","author":"Whalley","year":"2012","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"3","key":"10.1016\/j.brachy.2023.11.001_bib0003","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ctrv.2013.10.006","article-title":"High dose rate brachytherapy boost for prostate cancer: a systematic review","volume":"40","author":"Zaorsky","year":"2014","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"10.1016\/j.brachy.2023.11.001_bib0004","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.21873\/anticanres.16435","article-title":"Safety of carbon-ion radiotherapy for prostate cancer after rectal cancer surgery","volume":"43","author":"Takakusagi","year":"2023","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.brachy.2023.11.001_bib0005","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.ijrobp.2011.03.056","article-title":"The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer","volume":"82","author":"Defraene","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.11.001_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.954747","article-title":"The majority of United States citizens with cancer do not have access to carbon ion radiotherapy","volume":"12","author":"Foote","year":"2022","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.brachy.2023.11.001_bib0007","doi-asserted-by":"crossref","first-page":"533","DOI":"10.5114\/jcb.2020.101685","article-title":"High-dose-rate brachytherapy as monotherapy for localized prostate cancer using three different doses \u201314 years of single-centre experience","volume":"12","author":"Pietro","year":"2020","journal-title":"J Contemp Brachyther"},{"key":"10.1016\/j.brachy.2023.11.001_bib0008","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.radonc.2020.02.009","article-title":"Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy","volume":"146","author":"Morton","year":"2020","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.brachy.2023.11.001_bib0009","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.brachy.2022.01.005","article-title":"Efficacy and toxicity following salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after radiotherapy","volume":"21","author":"Kissel","year":"2022","journal-title":"Brachytherapy"},{"issue":"S3","key":"10.1016\/j.brachy.2023.11.001_bib0010","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.21037\/tau.2019.01.12","article-title":"Salvage prostate brachytherapy after definitive external radiation: tried and now tested","volume":"8","author":"Kwok","year":"2019","journal-title":"Transl Androl Urol"},{"issue":"3","key":"10.1016\/j.brachy.2023.11.001_bib0011","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ijrobp.2018.06.039","article-title":"Focal salvage high dose-rate brachytherapy for locally recurrent prostate cancer after primary radiation therapy failure: results from a prospective clinical trial","volume":"102","author":"Murgic","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.brachy.2023.11.001_bib0012","doi-asserted-by":"crossref","first-page":"414","DOI":"10.21037\/tau.2018.05.09","article-title":"The role of salvage brachytherapy for local relapse after external beam radiotherapy for prostate cancer","volume":"7","author":"Tisseverasinghe","year":"2018","journal-title":"Transl Androl Urol"},{"issue":"1","key":"10.1016\/j.brachy.2023.11.001_bib0013","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1016\/j.ijrobp.2019.06.124","article-title":"Salvage high dose rate brachytherapy for recurrent prostate cancer after definitive radiation","volume":"105","author":"Wu","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.brachy.2023.11.001_bib0014","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.brachy.2009.02.004","article-title":"High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience","volume":"8","author":"Jabbari","year":"2009","journal-title":"Brachytherapy"},{"issue":"4","key":"10.1016\/j.brachy.2023.11.001_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1120\/jacmp.v8i4.2415","article-title":"Measurement of craniocaudal catheter displacement between fractions in computed tomography\u2013based high dose rate brachytherapy of prostate cancer","volume":"8","author":"Kim","year":"2007","journal-title":"J Appl Clin Med Phys"},{"issue":"2","key":"10.1016\/j.brachy.2023.11.001_bib0016","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0360-3016(03)00131-7","article-title":"Analysis of interaction between number of implant catheters and dose\u2013volume histograms in prostate high- dose-rate brachytherapy using a computer model","volume":"56","author":"Charra-Brunaud","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.brachy.2023.11.001_bib0017","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.11.001_bib0018","unstructured":"NCCN. Guidlines Detail. Accessed November 1, 2023. Available at: https:\/\/www.nccn.org\/guidelines\/guidelines-detail."},{"issue":"1","key":"10.1016\/j.brachy.2023.11.001_bib0019","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.brachy.2011.07.005","article-title":"American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy","volume":"11","author":"Davis","year":"2012","journal-title":"Brachytherapy"},{"issue":"15","key":"10.1016\/j.brachy.2023.11.001_bib0020","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1200\/JCO.2016.72.0466","article-title":"Brachytherapy for patients with prostate cancer: American Society Of Clinical Oncology\/Cancer Care Ontario Joint Guideline Update","volume":"35","author":"Chin","year":"2017","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.brachy.2023.11.001_bib0021","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brachy.2020.07.011","article-title":"Real-world dosimetric comparison between CyberKnife SBRT and HDR brachytherapy for the treatment of prostate cancer","volume":"20","author":"Chatzikonstantinou","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.11.001_bib0022","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5114\/jcb.2019.85891","article-title":"Image-guided high-dose-rate brachytherapy for prostate cancer patients with previous rectal resection and pelvic irradiation: feasibility study","volume":"11","author":"Gruszczynska","year":"2019","journal-title":"J Contemp Brachyther"},{"key":"10.1016\/j.brachy.2023.11.001_bib0023","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/01.ju.0000146043.65229.9b","article-title":"Brachytherapy of prostate cancer after colectomy for colorectal cancer: pilot experience","volume":"173","author":"Koutrouvelis","year":"2005","journal-title":"J Urol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472123016823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472123016823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T10:57:08Z","timestamp":1711191428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472123016823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1538472123016823"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2023.11.001","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of high-dose rate (HDR) brachytherapy for patients with prostate cancer and history of prior chemoradiation for rectal cancer: A case series","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2023.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}